Exacerbation of bullous systemic lupus erythematosus with erythema gyratum repens-like pattern following dupilumab

By afschroeder • October 28, 2025

Santiago Mangual KP, Truong A, Mo J, Liu J, Khaligi MA, Haussmann A, Razmjou AA, Holland V, Cheng K. Exacerbation of bullous systemic lupus erythematosus with erythema gyratum repens-like pattern following dupilumab. JAAD Case Rep. 2025 Aug 29;65:206-210. doi: 10.1016/j.jdcr.2025.08.020. PMID: 41143219; PMCID: PMC12552150.

Tags: bullous pemphigoid, bullous systemic lupus erythematosus, Dermatology, DGSOM Student, Dupilumab, erythema gyratum repens, Fellow, Publications, Resident, Rheumatology, systemic lupus erythematosus

Chronic companions: An updated national cross-sectional study of metabolic syndrome comorbidities in outpatient visits for hidradenitis suppurativa

Ma EJ, Roberts AM, Chou P, Katz A, Jeong CY, Nong Y, Ochoa MT, Armstrong AW. Chronic companions: An updated national cross-sectional study of metabolic[...]

Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

Augustin M, Armstrong A, Issa NT, Petersen AS, von Eyben R, Festini T, Torres T. Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy[...]

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

Mayo T, Silverberg JI, Armstrong A, Guttman-Yassky E, Blauvelt A, Esdaile B, Kabashima K, Gooderham M, Kircik L, Schneider S, Bennike N, von Eyben R,[...]